Measurement of relative antioxidant activityof compounds: a methodological note

REFERENCES

• Gaziano JM. Antioxidant vitamins and coronary artery disease risk. Am J Med 1994; 97 (Suppl 3A): 185-218.
   PubMedGoogle Scholar
• Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721–724.
   PubMed Web of Science ®Google Scholar
• Hennekens CH. Antioxidant vitamins and cancer. Am J Med 1994; 97 (Suppl 3A): 2S-4S.
   PubMedGoogle Scholar
• Diplock A. Antioxidant nutrients — efficacy in disease prevention and safety. Biochemist 1995; 17: 16–18.
   Google Scholar
• Rice-Evans C. Antioxidant nutrients in protection against coronary heart disease and cancer. Biochemist 1995; 17: 8–11.
   Google Scholar
• Aruoma OI. Characterization of drugs as antioxidant prophylactics. Free Radic Biol Med 1996; 20: 675–705.
   PubMed Web of Science ®Google Scholar
• Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454–457.
   PubMed Web of Science ®Google Scholar
• Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007–1011.
   PubMed Web of Science ®Google Scholar
• Serafini M, Ghiselli A, Ferro-Luzzi A. Red wine, tea, and antioxidants. Lancet 1994; 344: 626.
   PubMed Web of Science ®Google Scholar
• Weisburger JH. Tea antioxidants and health. In: Cadenas E, Packer L, eds. Handbook of Antioxidants. New York: Marcel Dekker, 1996; 469–486.
   Google Scholar
• Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 1994; 97 (Suppl 3A): 5S-13S.
   PubMedGoogle Scholar
• Ioku K, Tsushida T, Takei Y, Nakatani N, Terao J. Antioxidative activity of quercetin and quercetin monoglucosides in solution and phospholipid bilayers. Biochim Biophys Acta 1995; 1234: 99–104.
   PubMed Web of Science ®Google Scholar
• van Acker SABE, van den Berg D-J, Tromp MNJL et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 1996; 20: 331–342.
   PubMed Web of Science ®Google Scholar
• Bors W, Heller W, Michel C, Stettmaier K. Flavonoids and polyphenols: chemistry and biology. In: Cadenas E, Packer L, eds. Handbook of Antioxidants. New York: Marcel Dekker, 1996; 409–466.
   Google Scholar
• Mathiesen L, Wang S, Halvorsen B, Malterud KE, Sund RB. Inhibition of lipid peroxidation in low-density lipoprotein by the flavonoid myrigalone B and ascorbic acid. Biochem Pharmacol 1996; 51: 1719–1725.
   PubMed Web of Science ®Google Scholar
• Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407–412.
   PubMed Web of Science ®Google Scholar
• Mira L, Silva M, Manso CF. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem Pharmacol 1994; 48: 753–759.
   PubMed Web of Science ®Google Scholar
• Mira L, Silva M, Manso CF. Antioxidant activity of silibinin against haemprotein dependent lipid peroxidation and DNA damage induced by bleomycin-Fe(III). In: Kumpulainem JT, Salonen JT, eds. Natural Antioxidants and Food Quality in Atherosclerosis and Cancer Prevention, no. 181. Cambridge: The Royal Society of Chemistry, 1996; 281-285.
   Google Scholar
• Lettéron P, Labbe G, Degott C et al. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice: evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol 1990; 39: 2027–2034.
   PubMed Web of Science ®Google Scholar
• Muriel P, Mourelle M. Prevention by silymarin of membrane alterations in acute CC14 liver damage. J Appl Toxicol 1990; 10: 275–279.
   PubMed Web of Science ®Google Scholar
• Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. The relative antioxidant activities of plantderived polyphenolic flavonoids. Free Radic Res 1995; 22: 375–383.
   PubMed Web of Science ®Google Scholar
• Rice-Evans CA, Diplock AT, Symons MCR. Transition metal complexes as sources of radicals. In: Burdon RH, van Knippenberg PH, eds. Laboratory Techniques in Biochemistry and Molecular Biology - Techniques in Free Radical Research, vol. 22. Amsterdam: Elsevier, 1991; 101-124.
   Google Scholar
• van Assendelft OW. Light absorption spectra of haemoglobin derivatives. In: Thomas CC, ed. Spectrophotometry of Haemoglobin Derivatives. Assen: Royal Vangorcum, 1970; 47–73.
   Google Scholar
• Terao J, Piskula M, Yao Q. Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys 1994; 308: 278–284.
   PubMed Web of Science ®Google Scholar
• Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 1995; 322: 339–346.
   PubMed Web of Science ®Google Scholar
• Miller NJ, Castelluccio C, Tijburg L, Rice-Evans C. The antioxidant properties of theaflavins and their gallate esters - radical scavengers or metal chelators? FEBS Lett 1996; 392: 40 14.
   Google Scholar
• Schwartner C, Michel C, Stettmaier K, Wagner H, Bors W. Marchantins and related polyphenols from liverwort: physico-chemical studies of their radical-scavenging properties. Free Radic Biol Med 1996; 20: 237–244.
   PubMed Web of Science ®Google Scholar
• Wasil M, Kelly FJ. Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine. Redox Rep 1995; 1: 361–367.
   PubMed Web of Science ®Google Scholar
• Strube M, Haenen GRMM, van der Berg H, Bast A. Pitfalls in a method for assessment of total antioxidant capacity. Free Radic Res 1997; 26: 515–521.
   PubMed Web of Science ®Google Scholar